Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients

NCT00051012

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States
  • Level 4 Department of Haematology Royal North Shore Hospital Saint Leonard's, New South Wales, Australia
  • Westmead Hospital, Department of Haematology Westmead, New South Wales, Australia
  • Mater Misericordiae Adult Hospital South Brisbane, Queensland, Australia
View all 34 locations
View Trial Details
Completed

VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma

NCT00085696

Conditions
B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
Locations
  • UCLA School of Medicine Los Angeles, California, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Emory University Cancer Institute, Winship Cancer Institute Atlanta, Georgia, United States
  • Georgia Cancer Specialists Marietta, Georgia, United States
View all 13 locations
View Trial Details
Completed

VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma

NCT00063713

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Alta Bates Medical Center Berkeley, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Loma Linda Cancer Research Institute Loma Linda, California, United States
View all 35 locations
View Trial Details
Completed

Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00090090

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +18 more
Locations
  • Alta Bates Cancer Center Berkeley, California, United States
  • Providence Saint Joseph Medical Center Burbank, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • Tower Hematology Oncology Medical Group Los Angeles, California, United States
View Trial Details
Completed

TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease

NCT00146211

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +23 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
View all 41 locations
View Trial Details
Completed

R-MegaCHOP-ESHAP-BEAM in Patients With High-Risk Aggressive B-Cell Lymphomas

NCT00558220

Conditions
Diffuse Large B-Cell Lymphoma., Follicular Lymphoma Grade III, Hemic and Lymphatic Diseases, +11 more
Locations
  • University Hospital Brno-Bohunice Brno, Czechia
  • Hospital Chomutov Chomutov, Czechia
  • Hospital České Budějovice České Budějovice, Czechia
  • University Hospital Hradec Králové Hradec Králové, Czechia
View Trial Details

Related conditions